Date | Insider | Price | Amount |
---|---|---|---|
11-4-2015 Insider Buy |
Scott A. Holmes Chief Financial Officer |
$5.33 CAGR » |
$26,629.13 5,000 shares |
8-21-2015 Insider Buy |
Scott A. Holmes Chief Financial Officer |
$5.72 CAGR » |
$28,590.00 5,000 shares |
8-12-2015 Insider Buy |
John F. Neylan Chief Medical Officer |
$6.20 CAGR » |
$62,000.00 10,000 shares |
5-6-2015 Insider Buy |
Michael P. Tarnok Director |
$9.73 CAGR » |
$97,300.00 10,000 shares |
4-18-2012 Insider Buy |
Ron Bentsur Chief Executive Officer |
$1.30 CAGR » |
$24,773.00 19,100 shares |
4-5-2012 Insider Buy |
Joseph M. Feczko Director |
$1.62 CAGR » |
$32,400.00 20,000 shares |
4-5-2012 Insider Buy |
Michael P. Tarnok Director |
$1.55 CAGR » |
$27,125.00 17,500 shares |
4-4-2012 Insider Buy |
Ron Bentsur Chief Executive Officer |
$1.38 CAGR » |
$98,524.86 71,400 shares |
Also See: Institutional Holders of KERX
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 11/05/2015 | |
End date: | 12/12/2018 | |
Start price/share: | $5.06 | |
End price/share: | $3.36 | |
Dividends collected/share: | $0.00 | |
Total return: | -33.60% | |
Average Annual Total Return: | -12.36% | |
Starting investment: | $10,000.00 | |
Ending investment: | $6,639.60 | |
Years: | 3.10 |
KERX Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent KERX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding KERX
Free KERX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |